Doximity, Inc. Class A Common Stock (DOCS)
R&D Expense Growth
-1.61%
Quarterly · Period ending:
DOCS R&D Expense Growth
Latest reported-1.61%period ending
Latest reported-1.61%period ending
DOCS Quarterly R&D Growth (QoQ) (0.00% → -1.61%)
Latest values, visible window
High-resolution chart · PNG
DOCS r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -1.6084% | |
| 13.0395% | |
| 14.5454% | |
| 12.6982% | |
| 8.0474% | |
| 10.624% | |
| -3.5241% | |
| 2.9503% | |
| 12.0409% | |
| 1.0127% | |
| -0.0601% | |
| -8.9964% | |
| 1.8105% | |
| 4.9807% | |
| 7.4068% | |
| 0.4311% | |
| 9.1713% | |
| 7.3898% | |
| 4.9483% | |
| 16.7586% | |
| 5.4388% | |
| 10.0999% | |
| 15.6092% | |
| -1.7624% | |
| 12.9569% | |
| 3.3236% | |
| 0% |